Trial · NCT04680975
Results by group32
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 32
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Combined Response Index in Diffuse Cutaneous Systemic Sclerosis (CRISS) Score at Week 24 | Belumosudil | 6.65 | Standard Deviation 12.926 | score on a scale | |
| Combined Response Index in Diffuse Cutaneous Systemic Sclerosis (CRISS) Score at Weeks 8, 16, 36, and 52 | Belumosudil | Week 8 | 13.97 | Standard Deviation 24.657 | score on a scale |
| Combined Response Index in Diffuse Cutaneous Systemic Sclerosis (CRISS) Score at Weeks 8, 16, 36, and 52 | Belumosudil | Week 16 | 20.48 | Standard Deviation 41.654 | score on a scale |
| Combined Response Index in Diffuse Cutaneous Systemic Sclerosis (CRISS) Score at Weeks 8, 16, 36, and 52 | Belumosudil | Week 36 | 22.38 | Standard Deviation 44.715 | score on a scale |
| Combined Response Index in Diffuse Cutaneous Systemic Sclerosis (CRISS) Score at Weeks 8, 16, 36, and 52 | Belumosudil | Week 52 | 25.49 | Standard Deviation 49.674 | score on a scale |
| Modified Rodnan Skin Score (mRSS) at Week 24 | Belumosudil | 24.2 | Standard Deviation 11.16 | score on a scale | |
| Forced Vital Capacity (FVC) Level at Week 24 | Belumosudil | 85.7 | Standard Deviation 25.28 | liters | |
| Physician Global Assessment of Participant's Overall Health Using Visual Analogue Scale (VAS) Score at Week 24 | Belumosudil | 61.2 | Standard Deviation 30.32 | score on a scale | |
| Patient Global Assessment of Participant's Overall Health Using Visual Analogue Scale (VAS) Score at Week 24 | Belumosudil | 51.3 | Standard Deviation 34.54 | score on a scale | |
| Scleroderma Health Assessment Questionnaire-Disability Index (SHAQ-DI) Total Score at Week 24 | Belumosudil | 1.750 | Standard Deviation 1.072 | score on a scale | |
| Change From Baseline in Modified Rodnan Skin Thickness Score (mRSS) at Weeks 8, 16, 36, and 52 | Belumosudil | Week 8 | -1.2 | Standard Deviation 2.82 | score on a scale |
| Change From Baseline in Modified Rodnan Skin Thickness Score (mRSS) at Weeks 8, 16, 36, and 52 | Belumosudil | Week 16 | -1.0 | Standard Deviation 4.86 | score on a scale |
| Change From Baseline in Modified Rodnan Skin Thickness Score (mRSS) at Weeks 8, 16, 36, and 52 | Belumosudil | Week 36 | 0.2 | Standard Deviation 6.57 | score on a scale |
| Change From Baseline in Modified Rodnan Skin Thickness Score (mRSS) at Weeks 8, 16, 36, and 52 | Belumosudil | Week 52 | -1.0 | Standard Deviation 8.98 | score on a scale |
| Change From Baseline in Forced Vital Capacity (FVC) Level at Weeks 8, 16, 36, and 52 | Belumosudil | Week 8 | 0.8 | Standard Deviation 4.15 | liters |
| Change From Baseline in Forced Vital Capacity (FVC) Level at Weeks 8, 16, 36, and 52 | Belumosudil | Week 16 | 2.9 | Standard Deviation 4.85 | liters |
| Change From Baseline in Forced Vital Capacity (FVC) Level at Weeks 8, 16, 36, and 52 | Belumosudil | Week 36 | 3.3 | Standard Deviation 9.32 | liters |
| Change From Baseline in Forced Vital Capacity (FVC) Level at Weeks 8, 16, 36, and 52 | Belumosudil | Week 52 | 0.8 | Standard Deviation 15.52 | liters |
| Change From Baseline in Physician Global Assessment (Reported by the Physician) Quantified of Participant's Overall Health Using Visual Analogue Scale (VAS) Score at Weeks 8, 16, 36, and 52 | Belumosudil | Week 8 | 0.1 | Standard Deviation 19.04 | score on a scale |
| Change From Baseline in Physician Global Assessment (Reported by the Physician) Quantified of Participant's Overall Health Using Visual Analogue Scale (VAS) Score at Weeks 8, 16, 36, and 52 | Belumosudil | Week 16 | 3.5 | Standard Deviation 19.72 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04680975/results